Cutting-Edge Technology
DISCOVER US
Innovative MyD88 Targeted Disease Solutions
Our integrated approach to MyD88-targeted drug development offers end-to-end solutions and specialized services focused on tackling complex disease areas. From discovery to clinical support, oursolutions are designed to accelerate therapeutic innovations.
-
-
Experienced Experts
-
Full-Service Support
-
Modern Facilities
-
Innovative Solutions
-
Quality Assurance
Our Featured Services
MyD88 Targeted Diseases
Featured Services
Therapeutic Discovery
Accelerating therapeutic breakthroughs with innovative discovery solutions tailored to your research needs.
Diseases Models
Building reliable disease models to enhance preclinical research accuracy and predictability.
Pharmacokinetics
Optimizing drug metabolism and pharmacokinetics to improve safety and efficacy profiles early in development.
Drug Safety Evaluation
Ensuring comprehensive safety evaluations to support regulatory submissions and mitigate potential risks.
IIT Services
Supporting investigator-led trials with end-to-end assistance to advance innovative therapies.
Autoimmune Diseases
- Multiple Sclerosis
- Psoriasis
- Rheumatoid Arthritis (RA)
- Systemic Lupus
- Erythematosus (SLE)
Inflammatory Diseases
- Bronchitis
- Chronic Hepatitis
- Endometritis
- Neurositis
- Vasculitis
Transplant Rejection
- Graft-Versus-Host Disease (GVHD)
Ischemia-Reperfusion Psoriasis
- Myocardial Infarction
- Stroke
Allergic Diseases
- Asthma
- Skin Allergies
Cancers
- Colorectal Cancer
- Diffuse large B-cell lymphoma
- Hepatocellular Carcinom
Neurodegenerative
- Alzheimer's Disease
- Dementia
- Parkinson's Disease
Metabolic Diseases
- Non-Alcoholic Fatty Liver Disease
- Type 1 Diabetes
- Type 2 Diabetes